Protecting Truth During Tension

As the Israeli-Palestinian conflict develops and the rise of hate crimes persists, TML is on the ground in the Middle East and beyond writing stories that readers like you and other media outlets rely on. To ensure that you have immediate access to unbiased, fact-based reporting, it is crucial that TML has the resources to disseminate these stories in real-time. Please help us protect the truth during these critical times by making a donation today.
The Media Line is proud to assume this responsibility and has over 20 years of success in shaping the role of news reporting in the region. We hope you will support our efforts by making a donation today.

In our modern, digital world, we are not as far away from each other as we once were, which is why news agencies have a responsibility to put forth reliable, trustworthy journalism more than ever before.
TML is proud to assume this responsibility.
We hope you will support our efforts.

Thank you!

Thank you for confidence in The Media Line.
 
Felice Friedson
Founder, President
How Close Are We to Finding a Coronavirus Vaccine?

How Close Are We to Finding a Coronavirus Vaccine?

Date: April 7

Time: 5 to 6 pm Australian Eastern Standard Time (3 am Eastern Daylight Time, 10 am Israel Daylight Time)

Location: Online via Zoom and Facebook

Cost: Free

Register here.

Join us for an interactive conversation with three global research leaders who will share an update on research related to combating coronavirus from an Israeli, Australian and global perspective.

Professor Alon Wolf, vice president for external relations and resource development + professor in the Faculty of Mechanical Engineering of the Technion- Israel Institute of Technology

Professor Debbie Lindell of the Technion- Israel Institute of Technology’s Faculty of Biology

Professor Michael Wallach of the University of Technology Sydney + visiting professor at the Technion – Israel Institute of Technology.

As countries worldwide take unprecedented steps to protect their populations from the coronavirus, an equally urgent race against time involves researchers working to halt the outbreak.

Hear from leading professors at the Technion and University of Technology Sydney as they explain what measures are taken in Israel, Australia and around the world to combat this epidemic.

The Technion has a proud history of medical innovations ranging from breakthrough drugs such as Azilect (for Parkinson’s disease); the Nobel-winning discovery of the ubiquitin system that continues to inform new cancer treatments; and technologies such as Novocure that uses electrical fields to kill tumors. These achievements arose from years of careful research.

Give the Gift of Trusted News!

Dear friends,

The Media Line is always there to report to you the stories and issues of the Middle East – completely and in context: TML is the source you can trust.

Know The Media Line to Know The Middle East!

Please support our ad-free, nonprofit news agency. Our seasoned journalists reporting from the Middle East are working day and night during these challenging, yet defining times; and our student interns are honing their knowledge and skills, preparing to emerge as tomorrow’s journalists.

You rely on us and we’re relying on you! Make your online tax-deductible donation here and contact us regarding donations through appreciated stock, donor advised funds, qualifying IRA distributions and other charitable instruments.

Thank you for confidence in The Media Line.
 
Felice Friedson
Founder, President

Invest in the
Trusted Mideast
News source.
We are on the
front lines.

Personalize Your News
Upgrade your experience by choosing the categories that matter most to you.
Click on the icon to add the category to your Personalize news
Browse Categories and Topics
Wake up to the Trusted Mideast News source Mideast Daily News Email
By subscribing, you agree to The Media Line terms of use and privacy policy.
Wake up to the Trusted Mideast News source Mideast Daily News Email
By subscribing, you agree to The Media Line terms of use and privacy policy.